Aortech International logo

AOR - Aortech International Share Price

110p 0.0  0.0%

Last Trade - 05/06/20

Micro Cap
Market Cap £17.8m
Enterprise Value £15.5m
Revenue £526k
Position in Universe 1393rd / 1817
Unlock AOR Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the six months ended 30 September 2019, AorTech International plc revenues increased 27% to £299K. Net loss decreased 28% to £158K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other expenses - amortisation of intangi decrease of 15% to £93K (expense), Exceptional administrative (expenses) / decrease from £2K (expense) to £0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


AOR Revenue Unlock AOR Revenue

Net Income

AOR Net Income Unlock AOR Revenue

Normalised EPS

AOR Normalised EPS Unlock AOR Revenue

PE Ratio Range

AOR PE Ratio Range Unlock AOR Revenue

Dividend Yield Range

AOR Dividend Yield Range Unlock AOR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AOR EPS Forecasts Unlock AOR Revenue
Profile Summary

AorTech International plc is a biomaterials and medical device intellectual property (IP) company. The Company is focused on the commercialization of its biomedical polymer technology, components and medical devices. The Company has developed biostable, implantable polymers, including Elast-Eon and ECSil, which are long-term implantable co-polymers. Its Elast-Eon technology is available in a range of mechanical properties (Elastomers to rigid polymers), 70 Shore A to 80 Shore D. Its ECSil technology is available in a range of mechanical properties, but extends the softer materials to 70 Shore A. The Company has developed Elast-Eon and Reaction Injection Molding (RIM) technology for use in high-precision medical device components. Its polymers are developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. These polymers can be processed using conventional thermoplastic extrusion and molding techniques.

Last Annual March 31st, 2019
Last Interim September 30th, 2019
Incorporated November 21, 1996
Public Since February 12, 1997
No. of Shareholders: n/a
No. of Employees: 3
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 16,186,608
Free Float (0.0%)
Eligible for
AOR Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for AOR
Upcoming Events for AOR
Tuesday 18th August, 2020 Estimate
Aortech International PLC Annual Shareholders Meeting
Frequently Asked Questions for Aortech International
What is the Aortech International share price?

As of 05/06/20, shares in Aortech International are trading at 110p, giving the company a market capitalisation of £17.8m. This share price information is delayed by 15 minutes.

How has the Aortech International share price performed this year?

Shares in Aortech International are currently trading at 110p and the price has moved by 81.82% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Aortech International price has moved by 0.108k% over the past year.

What are the analyst and broker recommendations for Aortech International?

Of the analysts with advisory recommendations for Aortech International, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Aortech International is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Aortech International next release its financial results?

Aortech International is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-09-30
What is the Aortech International dividend yield?

Aortech International does not currently pay a dividend.

Does Aortech International pay a dividend?

Aortech International does not currently pay a dividend.

When does Aortech International next pay dividends?

Aortech International does not currently pay a dividend.

How do I buy Aortech International shares?

To buy shares in Aortech International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Aortech International?

Shares in Aortech International are currently trading at 110p, giving the company a market capitalisation of £17.8m.

Where are Aortech International shares listed? Where are Aortech International shares listed?

Here are the trading details for Aortech International:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: AOR
What kind of share is Aortech International?

Based on an overall assessment of its quality, value and momentum, Aortech International is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Aortech International share price forecast 2020?

Shares in Aortech International are currently priced at 110p. At that level they are trading at 0.264% discount to the analyst consensus target price of 110.29.

Analysts covering Aortech International currently have a consensus Earnings Per Share (EPS) forecast of -0.0401 for the next financial year.

How can I tell whether the Aortech International share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aortech International. Over the past six months, the relative strength of its shares against the market has been 29.22%. At the current price of 110p, shares in Aortech International are trading at 40.36% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Aortech International PE Ratio?

We were not able to find PE ratio data for Aortech International.

Who are the key directors of Aortech International?

Aortech International's management team is headed by:

John McKenna - EDR
William Brown - CHM
Gordon Wright - NED
Kate Full - CFO
David Richmond - NED
Geoffrey Berg - NID
John Ely - NID
Who are the major shareholders of Aortech International?

Here are the top five shareholders of Aortech International based on the size of their shareholding:

Walker Crips Investment Management Limited Research Firm
Percentage owned: 12.49% (2.02m shares)
Richmond (David) Individual Investor
Percentage owned: 9.47% (1.53m shares)
Titcomb (Clive James) Individual Investor
Percentage owned: 4.76% (770k shares)
Hargreaves Lansdown Asset Management Limited Investment Advisor
Percentage owned: 4.17% (676k shares)
Wright (James Gordon) Individual Investor
Percentage owned: 3.96% (642k shares)
Similar to AOR
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.